Spinocerebellar Ataxias: Clinical Trials

148 trials for Spinocerebellar Ataxias, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

70 completed, 26 unknown, 17 recruiting, 14 active not recruiting. 53 Not applicable, 27 Phase 2, 17 Phase 3, 10 Phase 1, 3 Phase 4.

By phase and status

PhaseTrialsStatus
Not applicable53Completed 28, Unknown 10, Recruiting 7, Withdrawn 3, Active not recruiting 2, Not yet recruiting 2, Terminated 1
Phase 227Completed 16, Recruiting 3, Not yet recruiting 2, Terminated 2, Withdrawn 2, Active not recruiting 1, Unknown 1
Phase 317Completed 10, Active not recruiting 3, Terminated 3, Recruiting 1
Phase 110Completed 3, Recruiting 3, Unknown 2, Active not recruiting 1, Terminated 1
Phase 43Completed 2, Unknown 1
Early Phase 11Completed 1

Follow Spinocerebellar Ataxias: new trials by email Literature Review of Spinocerebellar Ataxias trials Research Report on Spinocerebellar Ataxias

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Umbilical Cord Mesenchymal Stem Cells Therapy (19#iSCLife®-SA) for Patients With Spinocerebellar Ataxia
Intravenous infusion, Intrathecal injection, umbilical cord mesenchymal stem cell - Spinocerebellar Ataxia Type 1, Spinocerebellar Ataxia Type 2
Phase 2Not yet recruitingSclnow Biotechnology Co., Ltd.452026-12-312026-04-23
Multi-Modal Digital Monitoring of Disease Symptoms in Spinocerebellar Ataxia
Spinocerebellar Ataxia (SCA)
Not yet recruitingBioSensics252026-12-152026-10-01
Biomarkers for Babies and Young Children With Ataxia Telangiectasia
Ataxia Telangiectasia
Not yet recruitingUniversity of Nottingham562026-09-012026-07-16
Rare Disease Registry Database for Movement Disorders in Southern Anhui Province
Motor Neuron Diseases, Spinocerebellar Ataxias
Active not recruitingFirst Affiliated Hospital of Wannan Medical College1802026-08-252026-09-24
Pivotal Study of N-acetyl-L-leucine for CACNA1A
N-Acetyl-L-Leucine, Placebo - CACNA1A, Spinocerebellar Ataxia Type 6
Phase 3RecruitingIntraBio Inc602026-08-172026-09-08
Optimizing Parameters of Transcranial Temporal Interference Stimulation for Spinocerebellar Ataxia Type 3
Transcranial Temporal Interference Stimulation (tTIS) - Spinocerebellar Ataxia Type 3
Not applicableNot yet recruitingFirst Affiliated Hospital of Fujian Medical University242026-08-072026-09-01
Safety and Efficacy of Mutation-targeted Precision Genetic Therapy for Ataxia-Telangiectasia (A-T)
Antisense oligonucleotide targeting the ATM gene - Ataxia Telangiectasia
Phase 1 / Phase 2RecruitingTimothy Yu102026-08-012026-05-28
Interposed Nucleus aDBS for Ataxia
Deep Brain Stimulation - Spinocerebellar Ataxia (SCA), Spinocerebellar Ataxia Type 6
Not applicableRecruitingUniversity of Florida52026-06-022026-07-20
Deep Brain Stimulation for Spinocerebellar Ataxia
Deep Brain Stimulation (DBS) - Spinocerebellar Ataxia (SCA), Spinocerebellar Ataxia Type 6
Not applicableRecruitingUniversity of California, San Francisco52026-04-272026-07-13
Use of a New Smartphone Application to Determine Changes in Eyeblink Conditioning From Home Training in Individuals With Spinocerebellar Ataxia
Aerobic Training, Balance Training - Spinocerebellar Ataxias
Not applicableWithdrawnColumbia University2026-01-012026-05-07
Autosomal Dominant Spinocerebellar Ataxias and Social Cognition
tests - Autosomal Dominant Spinocerebellar Ataxia (SCA1, 2,3,6,7,27B)
Not applicableRecruitingUniversity Hospital, Angers1602025-12-092026-07-20
An Phase Ib/II Clinical Trial of TCC1727 Combination Therapy in Advanced Solid Tumors
TCC1727 tablet 90mg, TCC1727 tablet 120mg, TCC1727 tablet 160mg - Solid Cancers, NSCLC (Advanced Non-small Cell Lung Cancer)
Phase 1 / Phase 2RecruitingBeijing Tide Pharmaceutical Co., Ltd2662025-12-032026-01-28
Ophthalmological Disorders in Dominant Spinal-cerebellar Ataxias
Neurological assessment, Ophthalmological assessment - Spinocerebellar Ataxia
Not applicableRecruitingUniversity Hospital, Montpellier602025-10-102025-11-20
Structural Validity and Inter-rater Reliabitiliy of the Ataxia Trunk, Lower And Upper Extremity Scale (ATLAS)
New Scale to evaluate ataxia motor symptoms - Ataxia, Cerebellar, Ataxia, Gait
Not yet recruitingHaute Ecole de Santé Vaud642025-09-012025-08-13
Stemchymal® for Polyglutamine Spinocerebellar Ataxia
Stemchymal, Placebo - Spinocerebellar Ataxias
Phase 2Not yet recruitingSteminent US, Inc.202025-06-012024-05-02
Efficacy of Cerebellar Transcranial Magnetic Stimulation to Treat Hereditary Spinocerebellar Ataxias
navigated iTBS (Intermittent theta-burst stimulation) targeting the cerebellum - Spinocerebellar Ataxias
Not applicableNot yet recruitingXijing Hospital802025-03-202025-03-27
A Pivotal Study of N-Acetyl-L-Leucine on Ataxia-Telangiectasia (A-T)
N-Acetyl-L-Leucine, Placebo - Ataxia-Telangiectasia, Ataxia-Telangiectasia (A-T)
Phase 3Active not recruitingIntraBio Inc602025-03-182025-07-03
Study of ARO-ATXN2 Injection in Adults With Spinocerebellar Ataxia Type 2
ARO-ATXN2 Injection, Placebo - Spinocerebellar Ataxia Type 2
Phase 1Active not recruitingArrowhead Pharmaceuticals392024-12-172026-06-29
Open-Label Extension of EryDex Study IEDAT-04-2022
Dexamethasone sodium phosphate - Ataxia Telangiectasia
Phase 3TerminatedQuince Therapeutics S.p.A.1012024-12-112026-05-05
Cycling-Based Priming Coordination Training for Enhancing Ataxia Recovery and Brain Plasticity
Cycling Training - Spinocerebellar Ataxias
Not applicableRecruitingChang Gung University402024-10-042024-10-08

Showing 20 of 148. Sign in to see all of them.

Narrower conditions

Ataxia Telangiectasia (42)  ·  Machado-Joseph Disease (32)  ·  Ataxia (24)  ·  Cerebellar Ataxia (15)  ·  Spinocerebellar Degenerations (12)  ·  Huntington Disease (6)  ·  Multiple System Atrophy (6)  ·  Neurodegenerative Diseases (5)  ·  Friedreich Ataxia (4)  ·  Spinocerebellar Ataxia 10 (4)  ·  Spinocerebellar ataxia 8 (4)  ·  Spinocerebellar ataxia, autosomal recessive 1 (4)  ·  Telangiectasis (4)  ·  Cerebellar Diseases (3)

Broader conditions

Congenital, Hereditary, and Neonatal Diseases and Abnormalities (148)  ·  Brain Diseases (147)  ·  Central Nervous System Diseases (147)  ·  Dyskinesias (147)  ·  Neurologic Manifestations (147)  ·  Genetic Diseases, Inborn (146)  ·  Nervous System Diseases (146)  ·  Cerebellar Diseases (145)  ·  Cerebellar Ataxia (133)  ·  Ataxia (124)  ·  Heredodegenerative Disorders, Nervous System (111)  ·  Spinal Cord Diseases (109)  ·  Neurodegenerative Diseases (106)  ·  Spinocerebellar Degenerations (96)

Interventions

Blood Specimen Collection (4)  ·  acetylleucine (4)  ·  Deep Brain Stimulation (3)  ·  Lithium Carbonate (3)  ·  Transcranial Direct Current Stimulation (3)  ·  Transcranial Magnetic Stimulation (3)  ·  nicotinamide-beta-riboside (3)  ·  Heptavalent Pneumococcal Conjugate Vaccine (2)  ·  IB1001 (2)  ·  Immunoglobulins, Intravenous (2)  ·  Magnetic Resonance Spectroscopy (2)  ·  Riluzole (2)  ·  Specimen Handling (2)  ·  Spinal Puncture (2)  ·  Trehalose (2)

Sponsors

Johann Wolfgang Goethe University Hospital (6)  ·  Chang Gung University (5)  ·  Hospital de Clinicas de Porto Alegre (5)  ·  Columbia University (4)  ·  IntraBio Inc (4)  ·  Johns Hopkins University (4)  ·  Kissei Pharmaceutical Co., Ltd. (4)  ·  Quince Therapeutics S.p.A. (4)  ·  Assistance Publique - Hôpitaux de Paris (3)  ·  Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia (3)  ·  Biohaven Pharmaceuticals, Inc. (3)  ·  Changhua Christian Hospital (3)  ·  Institut National de la Santé Et de la Recherche Médicale, France (3)  ·  University of Chicago (3)  ·  University of Florida (3)

Countries

United States (52)  ·  Germany (18)  ·  United Kingdom (16)  ·  Italy (15)  ·  France (14)  ·  Israel (10)  ·  Taiwan (10)  ·  Spain (9)  ·  Brazil (8)  ·  China (7)  ·  Australia (6)  ·  Switzerland (6)  ·  Belgium (4)  ·  Japan (4)  ·  Netherlands (4)

Top investigators

Stefan Zielen, Prof. Dr. (5)  ·  Theresa Zesiewicz, MD (4)  ·  Alberto Benussi, MD (3)  ·  Barbara Borroni, MD (3)  ·  Carlos Gordon, Prof. (2)  ·  Cherie Marvel, PhD (2)  ·  David Coman, MBBS FRACP (2)  ·  Dirk Thye, MD (2)  ·  Laura B. Jardim, MD, PhD (2)  ·  Vikram Shakkottai, MD, PhD (2)  ·  Ahmad Yasa MD (1)  ·  Alessandro Filla, MD (1)  ·  Alexander F. Karelin, PhD (1)

Results publications

PMID 24780882, PMID 34115419, PMID 34477998, PMID 40739200, PMID 15313841, PMID 15365159, PMID 16055926, PMID 16193476, PMID 16501573, PMID 16763896, PMID 16934683, PMID 17098887, PMID 17597328, PMID 17605047, PMID 17957230, PMID 18378516, PMID 18853458, PMID 19841031, PMID 22144182, PMID 22491195, PMID 22875082, PMID 22927201, PMID 23707147, PMID 24236946, PMID 24399647, PMID 25434572, PMID 25449974, PMID 25656498, PMID 25773989, PMID 26297649, PMID 26321318, PMID 26377379, PMID 26417459, PMID 26433381, PMID 26547562, PMID 26644294, PMID 26645295, PMID 26851119, PMID 26943780, PMID 27848087, PMID 28365204, PMID 28601294, PMID 28871440, PMID 28969699, PMID 29057148, PMID 29089256, PMID 29106465, PMID 29110179, PMID 29553382, PMID 29922574

NIH funding

2018 (2), 2025 (2), 2017 (1), R01DC016275 (1), R21NS085491 (1), R21NS094946 (1), R21NS125546 (1), U01NS106670 (1)